NCT02995278

Brief Summary

The purpose of this minimal risk, observational survey is to document the accuracy, benefits, and how qualitative and quantitative results affect patients' plan of care.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2016

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 6, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 16, 2016

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

January 23, 2019

Status Verified

January 1, 2019

Enrollment Period

3 years

First QC Date

December 6, 2016

Last Update Submit

January 22, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Plan of Care Changes due to Drug Screenings

    Provider based observational survey

    3 years

Interventions

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Providers who already drug screen for their current patient population.

You may qualify if:

  • Must be a Medical Practioner
  • Medical Doctor (MD)
  • Doctor of Osteopathic (DO)
  • Physician Assistant (PA)
  • Advanced Practice Registered Nurse (APRN)
  • Nurse Practioner (NP)
  • Must have a current standard operating procedure that includes obtaining/reviewing medical history.

You may not qualify if:

  • Government-funded insurance data cannot be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2016

First Posted

December 16, 2016

Study Start

October 1, 2016

Primary Completion

October 1, 2019

Study Completion

October 1, 2020

Last Updated

January 23, 2019

Record last verified: 2019-01